Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsResuscitation

ICU · Resuscitation

Septic shock: Surviving Sepsis Campaign 2021

Also known as Surviving Sepsis Campaign (SSC) · Sepsis-3 definition · Hour-1 bundle · qSOFA · SOFA score · Lactate clearance · Noradrenaline first-line · Vasopressin in septic shock · Hydrocortisone refractory shock · Source control sepsis

The Surviving Sepsis Campaign 2021 guidelines (Evans et al.) provide the evidence-based standard of care for sepsis and septic shock and are the single most examined document in critical-care fellowship exams. Sepsis-3 (Singer 2016) defines sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection (SOFA change =2 from baseline); septic shock is a subset with both vasopressor-dependent hypotension (MAP =65) AND lactate 2 mmol/L despite fluids — hospital mortality 40%. The SSC 2021 HOUR-1 BUNDLE (replaced the 3-hour and 6-hour bundles): within ONE hour of recognition - (1) measure lactate, (2) obtain blood cultures BEFORE antibiotics, (3) administer broad-spectrum antibiotics, (4) at least 30 mL/kg crystalloid within the first 3 h for sepsis-induced hypoperfusion or septic shock, (5) vasopressors to hold MAP =65. Noradrenaline FIRST-LINE; add vasopressin 0.03 U/min (fixed) when noradrenaline reaches the 0.25-0.5 mcg/kg/min range; hydrocortisone 200 mg/day for ongoing vasopressor requirement (ADRENAL — faster shock resolution; APROCCHSS — 90-day mortality benefit). Balanced crystalloids PREFERRED over saline (SMART). Restrictive fluid strategy after initial resuscitation is safe (CLASSIC, CLOVERS). MAP target 65 mmHg — no benefit of higher (SEPSISPAM, except less RRT at 80-85 in chronic hypertensives). Lactate clearance =20% per 2 h guides resuscitation (ANDROMEDA-SHOCK). Source control within 6-12 h is advantageous.

high31 referencesUpdated 26 July 202637 min readSource-verified · Sept 2026

Checked against its sources on 2 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Give antibiotics within 1 HOUR of recognition (SSC 2021, strong) — each hour of delay raises the odds of death (Seymour 2017, New York State cohort, 49,331 patients: OR 1.04/hour). In septic SHOCK or high-likelihood sepsis, do NOT delay antibiotics for cultures, imaging, or ICU transfer — screen for infection first only where it is timely.
  • Lactate >2 mmol/L is part of the septic-shock definition (Sepsis-3) and triggers the full hour-1 bundle; the 30 mL/kg crystalloid bolus is for sepsis-induced hypoperfusion or septic shock (SSC 2021). A normal lactate does NOT exclude septic shock if the patient is vasopressor-dependent.
  • Crystalloid ONLY — NO hydroxyethyl starch (increased mortality and AKI: CHEST, 6S). Balanced crystalloids (Hartmann/Plasma-Lyte/Ringer lactate) preferred over 0.9% saline (SMART — less MAKE30/AKI).
  • Target MAP >=65 mmHg — no benefit of a higher target in most patients (SEPSISPAM); higher targets only reasonable in chronic hypertensives to reduce RRT need.
  • Refractory shock = noradrenaline >=0.25-0.5 mcg/kg/min (or any second vasopressor) despite adequate fluids. Do NOT simply escalate noradrenaline — add vasopressin 0.03 U/min AND start hydrocortisone 200 mg/day (SSC 2021 weak suggestion). Continuing monotherapy escalation is inferior.
  • Source control within 6-12 h is NON-NEGOTIABLE — an undrained abscess, infected line, or necrotic tissue will NOT respond to antibiotics alone. Leaving an infected central line in situ while escalating vasopressors is a fatal error.
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Give antibiotics within 1 HOUR of recognition (SSC 2021, strong) — each hour of delay raises the odds of death (Seymour 2017, New York State cohort, 49,331 patients: OR 1.04/hour). In septic SHOCK or high-likelihood sepsis, do NOT delay antibiotics for cultures, imaging, or ICU transfer — screen for infection first only where it is timely.
  • Lactate >2 mmol/L is part of the septic-shock definition (Sepsis-3) and triggers the full hour-1 bundle; the 30 mL/kg crystalloid bolus is for sepsis-induced hypoperfusion or septic shock (SSC 2021). A normal lactate does NOT exclude septic shock if the patient is vasopressor-dependent.
  • Crystalloid ONLY — NO hydroxyethyl starch (increased mortality and AKI: CHEST, 6S). Balanced crystalloids (Hartmann/Plasma-Lyte/Ringer lactate) preferred over 0.9% saline (SMART — less MAKE30/AKI).
  • Target MAP >=65 mmHg — no benefit of a higher target in most patients (SEPSISPAM); higher targets only reasonable in chronic hypertensives to reduce RRT need.
  • Refractory shock = noradrenaline >=0.25-0.5 mcg/kg/min (or any second vasopressor) despite adequate fluids. Do NOT simply escalate noradrenaline — add vasopressin 0.03 U/min AND start hydrocortisone 200 mg/day (SSC 2021 weak suggestion). Continuing monotherapy escalation is inferior.
  • Source control within 6-12 h is NON-NEGOTIABLE — an undrained abscess, infected line, or necrotic tissue will NOT respond to antibiotics alone. Leaving an infected central line in situ while escalating vasopressors is a fatal error.

In one line

In one line

Sepsis = life-threatening organ dysfunction caused by a dysregulated host response to infection (SOFA change >=2 from baseline). Septic shock = sepsis + vasopressors for MAP >=65 + lactate >2 mmol/L despite fluids (hospital mortality >40%). SSC 2021 Hour-1 bundle: measure lactate, cultures before antibiotics, antibiotics within 1 h, at least 30 mL/kg crystalloid within the first 3 h for sepsis-induced hypoperfusion or septic shock, vasopressors for MAP >=65. Noradrenaline first-line; add vasopressin 0.03 U/min (fixed, not titrated) when noradrenaline reaches the 0.25-0.5 mcg/kg/min range; hydrocortisone 200 mg/day for refractory shock. Balanced crystalloids over saline (SMART); restrictive fluids after the initial bolus are safe (CLASSIC, CLOVERS). MAP >=65 is enough — no benefit of higher (SEPSISPAM, except less RRT with 80-85 in chronic hypertensives). Lactate clearance >=20% per 2 h guides resuscitation (ANDROMEDA-SHOCK). Source control within 6-12 h is non-negotiable. NO starch (6S, CHEST). NO vitamin C (LOVIT, CITRIS-ALI). NO rigid EGDT (ProCESS, ARISE, ProMISe).

[1] [2] [4] [8] [10] [19] [20]
ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References31ShowHide
  1. [1]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med, 2021.PMID 34599691
  2. [2]Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA, 2016.PMID 26903338
  3. [3]Seymour CW, Gesten F, Prescott HC, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis N Engl J Med, 2017.PMID 28528569
  4. [4]Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock N Engl J Med, 2014.PMID 24635770
  5. [5]Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock N Engl J Med, 2018.PMID 29347874
  6. [6]Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock N Engl J Med, 2018.PMID 29490185
  7. [7]Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock N Engl J Med, 2008.PMID 18184957
  8. [8]Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial JAMA, 2019.PMID 30772908
  9. [9]Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial JAMA, 2016.PMID 27483065
  10. [10]Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults N Engl J Med, 2018.PMID 29485925
  11. [11]Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock N Engl J Med, 2015.PMID 25776532
  12. [12]Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock N Engl J Med, 2014.PMID 25272316
  13. [13]Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock N Engl J Med, 2014.PMID 24635773
  14. [14]Lamontagne F, Masse MH, Menard J, et al. Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit N Engl J Med, 2022.PMID 35704292
  15. [15]Fowler AA 3rd, Truwit JD, Hite RD, et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial JAMA, 2019.PMID 31573637
  16. [16]Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med, 2008.PMID 18305265
  17. [17]Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis N Engl J Med, 2012.PMID 22738085
  18. [18]Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care N Engl J Med, 2012.PMID 23075127
  19. [19]Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock N Engl J Med, 2022.PMID 35709019
  20. [20]Shapiro NI, Douglas IS, Brower RG, et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension N Engl J Med, 2023.PMID 36688507
  21. [21]Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial Lancet, 2010.PMID 20097417
  22. [22]Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA, 2002.PMID 12186604
  23. [23]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med, 2010.PMID 20200382
  24. [24]Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock N Engl J Med, 2014.PMID 24635772
  25. [25]Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection N Engl J Med, 2018.PMID 29781385
  26. [26]Khanna A, English SW, Wang XS, et al. Angiotensin II for the Treatment of Vasodilatory Shock N Engl J Med, 2017.PMID 28528561
  27. [27]Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med, 2001.PMID 11794169
  28. [28]Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med, 2006.PMID 16625125
  29. [29]Keh D, Trips E, Marx G, et al. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial JAMA, 2016.PMID 27695824
  30. [30]Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock Ann Intern Med, 1984.PMID 6703540
  31. [31]Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial Lancet, 2007.PMID 17720019

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSeptic shock: SSC 2021 integrated — hour-1 bundle, vasopressors, and outcomesResuscitationNextSevere burns managementResuscitation